search
Back to results

Vitamin D3-enhanced Eggs in Preschool Children (VD3-egg)

Primary Purpose

Vitamin D Deficiency, 25-Hydroxyvitamin D3 Deficiency, Selective

Status
Completed
Phase
Not Applicable
Locations
Mexico
Study Type
Interventional
Intervention
vitamin D-enhanced egg
Control
Sponsored by
Instituto Nacional de Salud Publica, Mexico
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Vitamin D Deficiency focused on measuring Vitamin D3, enhanced egg, Vitamin D3-enhanced egg, 25-Hydroxyvitamin D3 Deficiency, supplementation, Mexico, Children

Eligibility Criteria

12 Months - 59 Months (Child)All SexesDoes not accept healthy volunteers

Inclusion Criteria: Children of either sex, from 12 to 59 months of age who attend take care SEDESOL centers Children who consume eggs within their usual diet at least 5 times per month Childrens whose parents or legal guardian agree to participate in the study and sign an informed consent letter Exclusion Criteria: Children with an egg allergy Chldren with hypersensitivity to vitamin D Children who have taken vitamin D supplements in the past month

Sites / Locations

  • Instituto Nacional de Salud Pública

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Placebo Comparator

Arm Label

vitamin D3-enhanced egg

Control

Arm Description

The experimental group consumed an vitamin D3-enhanced egg (~ 400 IU). The randomization unit was the take care SEDESOL centers. All children in 3 day-care centers were given one vitamin D3-enhanced egg at breakfast, 3 times a week for 12 weeks (Monday, Wednesday and Friday).

The control group consumed unfortified egg (~ 43 IU Vitamin D). The randomization unit was the 6 day-care centers (SEDESOL). All children in 3 day-care centers were given unfortified egg at breakfast, 3 times a week for 12 weeks (Monday, Wednesday and Friday).

Outcomes

Primary Outcome Measures

Serum 25-OH-D
nmol/L

Secondary Outcome Measures

Serum PTH
pcg/mL

Full Information

First Posted
September 4, 2023
Last Updated
October 19, 2023
Sponsor
Instituto Nacional de Salud Publica, Mexico
Collaborators
DSM Nutritional Products, Inc.
search

1. Study Identification

Unique Protocol Identification Number
NCT06096194
Brief Title
Vitamin D3-enhanced Eggs in Preschool Children
Acronym
VD3-egg
Official Title
Effect of the Consuption of Vitamin D3-enhanced Eggs on Serum 25-hydroxivitamin D[(25-OH)D3] and Parathyroid Hormone (PTH) in Preschool Children
Study Type
Interventional

2. Study Status

Record Verification Date
October 2023
Overall Recruitment Status
Completed
Study Start Date
July 15, 2018 (Actual)
Primary Completion Date
November 30, 2018 (Actual)
Study Completion Date
December 21, 2019 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Instituto Nacional de Salud Publica, Mexico
Collaborators
DSM Nutritional Products, Inc.

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Product Manufactured in and Exported from the U.S.
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
This is double-blind, controlled fiel trial, to compare fortified egg with D3-or 25(OH)D3 and non-fortified eggs in healthy preschool-age children 12 to 60 months of age, affiliated to day-care centers at Secretaria de Desarrollo Social (SEDESOL). The study aims to answer are: to evaluate the efficacy of fortified egg with vitamian D3 on serum concentrations of 25-hydroxyvitamin D3 and to evaluate parathyroid hormone (PTH) in children aged 12 to 60 months of age. Children would be given for breakfast fortified egg/non-foritfied egg three times per week for 12 weeks. Blood samples will be taken at baseline and at the end of study. Anthropometric meassurements weight /height will be taken at baseline and at end of study.
Detailed Description
Vitamin D functions: Vitamin D (VD) is a fat-soluble vitamin. Its main function is to maintain optimal levels of calcium and phosphorus in the body; it also helps in neuromuscular transmission and bone mineralization, important in bone health and growth in children. There are VD receptors in bone, bone marrow, adipose tissue, adrenal, brain, stomach, small intestine, colon, pancreas, liver, lung, muscle, activated B and T lymphocytes, and in other organs, tissues, and cells. For this reason, various functions are assumed. VD serum concentrations above 75 mmol/l (30 ng/ml) have been shown to keep cell growth under control and prevent cells from becoming autonomous and malignant. Prevalences of vitamin D deficiencies and insufficiency: Worldwide, a high proportion of children, youth, and middle-aged adults are deficient in Vitamin D. It has been estimated that about one billion people in the world may be deficient in Vitamin D. In Latin America, only Mexico has representative population data on vitamin D deficiency. Recently it has been documented that the deficiency and insufficiency of Vitamin D are a public health problem in Mexico. In a national representative sample of 6,827 children aged 1 to 11 years who participated in the 2012 National Health and Nutrition Survey (ENSANUT), the prevalence of Vitamin D deficiency was 33% (25-OH-D <50 nmol/L), which means that there are 3 million children with Vitamin D deficiency in Mexico. On the other hand, insufficiency (25-OH-D of 50 <75 nmol/L) affects 56% of children. Likewise, it was found that less than 3% of children consume a supplement with Vitamin D. Vitamin D intake recommendations in children: The current vitamin D intake recommendations made by the APP since 2008 (Wagner CL, 2008) for children aged 1 to 8 years is an Adequate Intake of 400-600 IU (10-15µg), and for the Tolerable Upper Intake Level it is suggested do not exceed 2500 IU (63µg) in the case of children from 1 to 3 years and 3000 IU (75µg) in children from 4 to 8 years. Description of the study: A double-blind controlled cluster randomized field trial was developed. The participants were children from 6 day-care centers (SEDESOL) at Cuernavaca, Morelos, Mexico. The study sample had 275 children that completed the study (the protocol considered having at least 125 children in each treatment group), from 12 to 59 months, who attended 6 take care centers (SEDESOL), in Cuernavaca, Morelos. Objective To evaluate the efficacy of the consumption of fortified eggs with Vitamin D3 on the serum concentrations of 25-OH-D in children aged 12 to 59 months who attend take care centers (SEDESOL)in Cuernavaca. Treatment and control groups: The random assignments of the intervention group (fortified egg) and control group (unfortified egg) were done considering each day-care center as a unit of allocation. Three day-care centers were randomized to the intervention group and three to the control group. The study lasted 12 weeks. The treatment group consumed a fortified egg to provide 10 mcg of Vitamin D3 equivalent to 400 IU of Cholecalciferol, 3 times a week. The control group received unfortified egg (~ 43 IU Vitamin D) with the same frequency as the intervention group. Main Outcomes: The main outcome outcome variables were the serum levels of 25-hydroxyvitamin D3 (25-OH-D3) The second main outcome was to evaluate the parathyroid hormone (PTH). Other Variables: Blood parameters were taken: total cholesterol, HDL cholesterol, triglycerides, glucose, and hemoglobin. Anthropometric measurements of weight, height, age. Morbidity (diarrhea, constipation and respiratory tract infections) was evaluated three times per week and recorded. Standardized personnel weight the egg consumed before and after breakfast with a food weighing scale. Mothers were asked about children's usual diet by two diet questionnaires : a 24-hour dietary recall and a food frequency questionnaire at baseline and at the end of the study. Ethical considerations: The protocol was submitted to he Research and Ethics Committee of the Medicine Research Division of the National Autonomous University of Mexico.The study was approved on May 8, 2018 with folio FM/DI/028/2018. The children's mothers or guardians signed an informed consent letter.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Vitamin D Deficiency, 25-Hydroxyvitamin D3 Deficiency, Selective
Keywords
Vitamin D3, enhanced egg, Vitamin D3-enhanced egg, 25-Hydroxyvitamin D3 Deficiency, supplementation, Mexico, Children

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Randomized Double Blind field trial
Masking
ParticipantCare ProviderOutcomes Assessor
Masking Description
Two types of eggs. Control egg and fortified egg (vitamin D3-enhanced egg), only the researcher in charge of eggs production was not blinded
Allocation
Randomized
Enrollment
275 (Actual)

8. Arms, Groups, and Interventions

Arm Title
vitamin D3-enhanced egg
Arm Type
Experimental
Arm Description
The experimental group consumed an vitamin D3-enhanced egg (~ 400 IU). The randomization unit was the take care SEDESOL centers. All children in 3 day-care centers were given one vitamin D3-enhanced egg at breakfast, 3 times a week for 12 weeks (Monday, Wednesday and Friday).
Arm Title
Control
Arm Type
Placebo Comparator
Arm Description
The control group consumed unfortified egg (~ 43 IU Vitamin D). The randomization unit was the 6 day-care centers (SEDESOL). All children in 3 day-care centers were given unfortified egg at breakfast, 3 times a week for 12 weeks (Monday, Wednesday and Friday).
Intervention Type
Dietary Supplement
Intervention Name(s)
vitamin D-enhanced egg
Intervention Description
In our study, the vitamin D3-enhanced eggs were produced by hens that received 23,500 IU of vitamin D3 per kg of feed. Which does not confer them any harm or danger of intoxication. This experiment was carried out at the Center for Teaching, Research and Extension in Poultry Production (CEIEPAv, FMVZ-UNAM) and lasted 40 weeks. This ensured that the hens eggs were enhanced with vitamin D achieving a final concentration of approximately 400 IU of vitamin D
Intervention Type
Other
Intervention Name(s)
Control
Intervention Description
Unfortified eggs were used for the control group with a concentration of approximately 43 IU of vitamin D
Primary Outcome Measure Information:
Title
Serum 25-OH-D
Description
nmol/L
Time Frame
At baseline and at 12 weeks of intervention
Secondary Outcome Measure Information:
Title
Serum PTH
Description
pcg/mL
Time Frame
At baseline and at 12 weeks of intervention
Other Pre-specified Outcome Measures:
Title
Insulin
Description
ug/dL
Time Frame
At baseline and at 12 weeks of intervention
Title
Weight
Description
kg
Time Frame
At baseline and at 12 weeks of intervention
Title
Height
Description
cm
Time Frame
At baseline and at 12 weeks of intervention
Title
Total Cholesterol
Description
mg/dL
Time Frame
At baseline and at 12 weeks of intervention
Title
Triglicerids
Description
mg/dL
Time Frame
At baseline and at 12 weeks of intervention
Title
HDLc
Description
mg/dL
Time Frame
At baseline and at 12 weeks of intervention
Title
Glucose
Description
mg/dL
Time Frame
At baseline and at 12 weeks of intervention

10. Eligibility

Sex
All
Minimum Age & Unit of Time
12 Months
Maximum Age & Unit of Time
59 Months
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Children of either sex, from 12 to 59 months of age who attend take care SEDESOL centers Children who consume eggs within their usual diet at least 5 times per month Childrens whose parents or legal guardian agree to participate in the study and sign an informed consent letter Exclusion Criteria: Children with an egg allergy Chldren with hypersensitivity to vitamin D Children who have taken vitamin D supplements in the past month
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Mario E Flores Aldana, PhD
Organizational Affiliation
National Institute of Public Health, Mexico
Official's Role
Principal Investigator
Facility Information:
Facility Name
Instituto Nacional de Salud Pública
City
Cuernavaca
State/Province
Morelos
ZIP/Postal Code
62100
Country
Mexico

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Vitamin D3-enhanced Eggs in Preschool Children

We'll reach out to this number within 24 hrs